Wegovy is a licensed treatment for weight loss and weight maintenance, intended to be used in conjunction with diet and exercise in adults. Wegovy contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist. It helps improve blood glucose control, reduce appetite, and increase satiety. In clinical trials, participants using Wegovy lost up to 15% body weight. Evidence suggests that using Wegovy in addition to diet and exercise is more effective than diet and exercise alone. Your program includes a prescription of Wegovy, weight tracking, and additional help from medical professionals in your weight loss journey. If you haven't used any weight loss medication in the past two weeks, you will be prescribed the 0.25mg starting dose.
